Ketcher 12111915162D 1 1.00000 0.00000 0 22 25 0 1 0 999 V2000 11.3789 -11.2010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10.4278 -10.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3789 -12.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2449 -10.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8401 -11.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4278 -12.5100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2449 -12.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1110 -11.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2449 -9.7010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.1188 -13.4611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1110 -12.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8456 -11.5964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4388 -10.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0266 -9.8739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.0211 -9.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.9645 -9.8161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.7566 -10.7942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8430 -11.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9770 -10.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.4257 -11.5374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.9257 -12.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.9475 -12.1955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 1 3 1 0 0 0 1 4 1 0 0 0 2 5 2 0 0 0 3 6 2 0 0 0 3 7 1 0 0 0 4 8 1 0 0 0 4 9 2 0 0 0 6 10 1 0 0 0 7 11 1 0 0 0 5 6 1 0 0 0 8 11 1 0 0 0 5 12 1 0 0 0 12 13 2 0 0 0 13 14 1 0 0 0 14 15 2 0 0 0 15 2 1 0 0 0 16 17 1 0 0 0 17 18 2 0 0 0 18 19 1 0 0 0 8 19 1 1 0 0 17 20 1 0 0 0 20 21 1 0 0 0 21 22 2 0 0 0 18 22 1 0 0 0 M END > CHEBI:31588 > fabesetron > An organic heterotricyclic compound that is 8,9-dihydropyrido[1,2-a]indol-6(7H)-one substituted by a (5-methyl-1H-imidazol-4-yl)methyl group at position 7R and a methyl group at position 10. It is a dual 5-HT3 and 5-HT4 receptors antagonist whose clinical development was terminated in phase II. It was being developed for the treatment of chemotherapy-induced emesis and irritable bowel syndrome. > 3 > FK1052; FK-1052; FK 1052; (+)-(R)-8,9-dihydro-10-methyl-7-((5-methylimidazol-4-yl)methyl)pyrido[1,2-a]indol-6(7H)-one > (7R)-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one > fabesetronum; fabesetron; fabesetron; fabesetron > C18H19N3O > 293.370 > 293.15281 > 0 > N12C3=C(C(=C1CC[C@@H](C2=O)CC4=C(C)NC=N4)C)C=CC=C3 > InChI=1S/C18H19N3O/c1-11-14-5-3-4-6-17(14)21-16(11)8-7-13(18(21)22)9-15-12(2)19-10-20-15/h3-6,10,13H,7-9H2,1-2H3,(H,19,20)/t13-/m1/s1 > AEKQMJRJRAHOAP-CYBMUJFWSA-N > 129300-27-2 > 129300-27-2 > 10688616; 11560875; 16079468; 7553979; 7697771; 7697772; 8331576; 8496821; 8944700 $$$$